{
  "id": 9275571,
  "title": "Ozempic-maker Novo open to upgrading US listing",
  "url": "https://urgent.news/2026/09/23/ozempic-maker-novo-open-to-upgrading-us-listing",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-23T04:00:29.000Z",
  "source": {
    "name": "Financial Times",
    "slug": "financial-times",
    "url": "https://www.ft.com/content/00d53ca3-725f-4fa8-b452-cef562a13514?syn-25a6b1a6=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Boss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FT",
        "url": "https://urgent.news/2026/09/23/novo-nordisk-open-to-new-york-listing-upgrade-ceo-doustdar-tells-ft",
        "published": "2026-09-23T04:19:08.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}